Similar to results obtained from flow cytometry analysis, we detected increased proportion of CD14+HLADR+ cells (cluster 1) in AD-PBMCs, compared to the CON-PBMCs, especially in AD-PBMCs treated with CSF and LPS (Fig. 5e). This evidence concerns the gene CD14 and Alzheimer disease.